Variant report
Variant | nsv4431 |
---|---|
Chromosome Location | chr4:94547397-94566762 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180724681 | chr4:94554726-94554727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576161968 | chr4:94554750-94554751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1108563 | chr4:94554762-94554763 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs186225937 | chr4:94554789-94554790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191895810 | chr4:94554799-94554800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1108562 | chr4:94554804-94554805 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs541372748 | chr4:94554822-94554823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564162967 | chr4:94554833-94554834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182592616 | chr4:94554836-94554837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555876689 | chr4:94554851-94554852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538620064 | chr4:94554852-94554853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371024876 | chr4:94554864-94554865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1108561 | chr4:94554917-94554918 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs115355006 | chr4:94554935-94554936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569654154 | chr4:94554948-94554949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532129179 | chr4:94554985-94554986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572731138 | chr4:94554992-94554993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552215230 | chr4:94555002-94555003 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116723366 | chr4:94555006-94555007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1108560 | chr4:94555018-94555019 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs529130115 | chr4:94555044-94555045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186727462 | chr4:94555062-94555063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568052994 | chr4:94555069-94555070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555189323 | chr4:94555128-94555129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115522084 | chr4:94555186-94555187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190488308 | chr4:94555235-94555236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576002194 | chr4:94555317-94555318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140310543 | chr4:94555374-94555375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116791236 | chr4:94555476-94555477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183055118 | chr4:94555481-94555482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572556925 | chr4:94555534-94555535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187069381 | chr4:94555541-94555542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371344500 | chr4:94555553-94555554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561459073 | chr4:94555577-94555578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544335672 | chr4:94555612-94555613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190298680 | chr4:94555669-94555670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367868873 | chr4:94555711-94555712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548911681 | chr4:94555731-94555732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs76944852 | chr4:94555742-94555743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577737809 | chr4:94555751-94555752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545050180 | chr4:94555760-94555761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532091926 | chr4:94555774-94555775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551989233 | chr4:94555777-94555778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1369467 | chr4:94555780-94555781 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs528162796 | chr4:94555795-94555796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1369468 | chr4:94555824-94555825 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs571683493 | chr4:94555920-94555921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567890575 | chr4:94555949-94555950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536972237 | chr4:94555957-94555958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140707842 | chr4:94555982-94555983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Epilepsy | 20502679 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:94554600-94555000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr4:94554800-94555200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:94555000-94555400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr4:94555200-94555600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr4:94555400-94556000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr4:94555800-94556000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr4:94565400-94565800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr4:94565400-94566000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
9 | chr4:94565400-94567000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr4:94565800-94566200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr4:94565800-94566600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:94566000-94566200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr4:94566000-94567800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr4:94566200-94570600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr4:94566200-94570600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
16 | chr4:94566600-94567200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |